Willis-Knighton seeking participants for COVID-19 treatment clinical trial,

The hospital system is expanding its clinical trial for the Regeneron monoclonal antibodies for outpatient treatment of people infected with COVID-19., The hospital system is expanding its clinical trial for the Regeneron monoclonal antibodies for outpatient treatment of people infected with COVID-19., Read More

Scroll to Top